• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Medgadget Visits Healthcareᐩ Expo Taiwan

      Medgadget Visits Healthcareᐩ Expo Taiwan

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

    • Radiology
      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Exciting Medtech at the Healthcareᐩ Expo Taiwan

      Fluorescence Imaging System Illuminates Tumor Depth

      Fluorescence Imaging System Illuminates Tumor Depth

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Soft Robot Grows Like a Plant to Travel Through Tight Spaces

      Mining Ultrasound Data to Improve Liver Diagnostics: Interview with Beth Rogozinski, CEO at Oncoustics

      Mining Ultrasound Data to Improve Liver Diagnostics: Interview with Beth Rogozinski, CEO at Oncoustics

    • Cardiology
      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

      Camera Measures Blood Pressure with Quick Look

      Camera Measures Blood Pressure with Quick Look

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

    • Surgery
      Biobots Use Optogenetic Muscle Actuators for Movement

      Biobots Use Optogenetic Muscle Actuators for Movement

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Electrospun Construct Mimics Elasticity of Blood Vessels

      Electrospun Construct Mimics Elasticity of Blood Vessels

    • Nanomedicine
      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Magnetic Bacteria Target Tumors

      Magnetic Bacteria Target Tumors

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Implanted Magnets for Prosthetic Control

      Implanted Magnets for Prosthetic Control

      FDA-Approved At-Home Spirometer: Interview with Charvi Shetty, Co-Founder and CEO at Aluna

      FDA-Approved At-Home Spirometer: Interview with Charvi Shetty, Co-Founder and CEO at Aluna

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Global Cancer Monoclonal Antibodies Market &Clinical Trial Insight 2024

December 5th, 2018 PNS Pharma Releases

 “Global Cancer Monoclonal Antibodies  Market & Clinical Trial Insight 2024” Report Highlights: 

  • Significance for Monoclonal Antibodies for Cancer Treatment
  • Global Cancer Monoclonal Antibodies Market Overview
  • Global Cancer Monoclonal Antibodies Pipeline by Phase & Indication
  • Global Cancer Monoclonal Antibodies Pipeline: 697 mAb
  • Marketed Cancer Monoclonal Antibodies: 60
  • Global Cancer Monoclonal Antibodies Market Opportunity: US$ 140 Billion

Download Report:

http://www.pnspharma.com/buy-report.php?reporttitle=Global-Cancer-Monoclonal-Antibodies–Market-%26Clinical-Trial-Insight-2024

The recent years have witnessed the emergence of monoclonal antibodies, which has the potential to offer less toxic and more efficient therapeutic alternatives for patients. Over the past decades, the researchers have increased their learning about the human body’s immune system, which has led to the achievement of significant number of regulatory milestones during this period. The use of mAbs for treating cancer has increased significantly. The rising market availability of these agents has enabled the pharmaceutical companies to develop novel combination approaches which have the capability to provide even greater insight into the body’s immune system so as to develop more efficient mAbs.

 

Report TOC

 

  1. Introduction to Monoclonal Antibodies

1.1 History of Development

1.2 Working of Monoclonal Antibodies

 

  1. Monoclonal Antibodies Classification

2.1 Naked Monoclonal Antibodies

2.2 Conjugated Monoclonal Antibodies

2.2.1 Radiolabeled Antibodies

2.2.2 Chemolabeled Antibodies

2.2.3 Immunotoxins

 

  1. Monoclonal Antibodies Mechanisms

3.1 Tumor Antigens as Targets of Antibodies

3.2 Development of Antibodies for Clinical Purposes

3.3 Complement Dependent Cytotoxicity (CDC)

3.4 Signal Transduction Changes

 

  1. Significance for Monoclonal Antibodies for Cancer Treatment

 

  1. Global Cancer Monoclonal Antibodies Market Overview

5.1 Current Market Scenario

5.2 Clinical Pipeline Insight

 

  1. Global Cancer Monoclonal Antibodies Market Future Outlook

 

  1. Global – Bladder Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

7.1 Phase-I/II

7.2 Phase-II

7.3 Phase-III

 

  1. Marketed Bladder Cancer Monoclonal Antibodies Clinical Insight

8.1 Durvalumab (Imfinzi)

 

  1. Global – Blood Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

9.1 Unknown

9.2 Research

9.3 Preclinical

9.4 Clinical

9.5 Phase-I

9.6 Phase-I/II

9.7 Phase-II

9.8 Phase-III

9.9 Preregistration

 

  1. Marketed Blood Cancer Monoclonal Antibodies Clinical Insight

10.1 Daratumumab (DARZALEX)

10.2 Ofatumumab (Arzerra)

10.3 Obinutuzumab (GAZYVA, Gazyva & Gazyvaro)

10.4 Blinatumomab (Blincyto)

10.5 Elotuzumab (Empliciti)

10.6 Mogamulizumab (Poteligeo)

10.7 Alemtuzumab (Campath, Lemtrada, MabCampath, MabKampat & Remniq)

10.8 Brentuximab Vedotin (Adcetris)

10.9 Inotuzumab Ozogamicin (BESPONSA & Besponsa)

10.10 Rituximab Biosimilar (AcellBia, Acellbia & USMAL)

10.11 Rituximab Biosimilar (Blitzima, Ritemvia, Truxima & Tuxella)

10.12 Rituximab Biosimilar (Rixathon & Riximyo)

10.13 Gemtuzumab Ozogamicin (Mylotarg)

10.14 Ibritumomab Tiuxetan (Zevalin & Zevamab)

10.15 Rituximab Biosimilar (REDDITUX, Reditux & Tidecron)

10.16 Rituximab Biosimilar (Novex)

10.17 Rituximab Biosimilar (CIMAbior & RituxCIM)

10.18 Rituximab/Hyaluronidase (MabThera SC, RITUXAN SC & Rituxan Hycela)

10.19 Rituximab Biosimilar (Zytux)

10.20 Rituximab Biosimilar (RituxiRel, Toritz & Toritz RA)

10.21 Rituximab Biosimilar (Maball)

10.22 Rituximab Biosimilar (Kikuzubam)

10.23 Rituximab Biosimilar (Mabtas)

 

  1. Global – Breast Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

11.1 Unknown

11.2 Research

11.3 Preclinical

11.4 Phase-I

11.5 Phase-II

11.6 Phase-III

11.7 Preregistration

11.8 Registered

 

  1. Marketed Breast Cancer Monoclonal Antibodies Clinical Insight

12.1 Trastuzumab Subcutaneous (Herceptin SC)

12.2 Pertuzumab (Omnitarg & Perjeta)

12.3 Trastuzumab Biosimilar (CANMAb, Hertraz, Ogivri & Zedora)

12.4 Trastuzumab Emtansine (Kadcyla)

12.5 Trastuzumab Biosimilar (Vivitra)

 

  1. Global Bone Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

13.1 Phase-III

 

  1. Marketed Bone Cancer Monoclonal Antibodies Clinical Insight

14.1 Denosumab (PRALIA, Prolia, Ranmark & Xgeva)

 

  1. Global – Brain Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

15.1 Preclinical

15.2 Phase-I/II

15.3 Phase-III

15.4 Registered

 

  1. Marketed Brain Cancer Monoclonal Antibodies Clinical Insight

16.1 Dinutuximab (Unituxin)

 

  1. Global – Cervical Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

17.1 Phase-I/II

 

  1. Global – Colorectal Cancer Monoclonal Antibodies Clinical pipeline by Company & Phase

18.1 Unknown

18.2 Preclinical

18.3 Phase-I

 

  1. Global – Head and Neck Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

19.1 Preclinical

19.2 Phase-I/II

19.3 Phase-III

 

  1. Global – Liver Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

20.1 Phase-II

 

  1. Global – Kidney Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

21.1 Preclinical

21.2 Phase-II

21.3 Phase-III

 

  1. Global – Skin Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

22.1 Research

22.2 Preclinical

22.3 Phase-I

22.4 Phase-I/II

22.5 Phase-II/III

22.6 Phase-III

22.7 Preregistration

 

  1. Marketed Skin Cancer Monoclonal Antibodies Clinical Insight

23.1 Avelumab (BAVENCIO)

23.2 Olaratumab (Lartruvo)

 

  1. Global – Stomach Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

24.1 Preclinical

24.2 Phase-I/II

24.3 Phase-II

24.4 Phase-III

24.5 Preregistration

 

  1. Marketed Stomach Cancer Monoclonal Antibodies Clinical

25.1 Bevacizumab Biosimilar (Bevax)

25.2 Cetuximab Biosimilar – CinnaGen

25.3 Bevacizumab Biosimilar (Cizumab)

 

 

  1. Global – Lung Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

26.1 Research

26.2 Clinical

26.3 Phase-I

26.4 Phase-I/II

26.5 Phase-II

26.6 Phase-II/III

26.7 Phase-III

26.8 Preregistration

26.9 Registered

 

  1. Marketed Lung Cancer Monoclonal Antibodies Clinical Insight

27.1 Necitumumab (Portrazza)

27.2 Iodine I 131 Derlotuximab Biotin (Cotara)

27.3 Bevacizumab Biosimilar (Bryxta)

27.4 Racotumomab (Vaxira)

27.5 Racotumomab (Vaxira)

27.6 Tc 99m Nofetumomab Merpentan (VerLuma)

 

  1. Global – Ovarian Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

28.1 Research

28.2 Preclinical

28.3 Phase-I

28.4 Phase-I/II

28.5 Phase-II

 

  1. Global – Pancreatic Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

29.1 Preclinical

29.2 Phase-I

29.3 Phase-I/II

29.4 Phase-II

 

  1. Marketed Pancreatic Cancer Monoclonal Antibodies Clinical Insight

30.1 Gemcitabine elaidate companion diagnostic – Ventana Medical Systems/Clovis Oncology

 

  1. Global – Prostate Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

31.1 Preclinical

31.2 Phase-II

 

  1. Global – Multiple Cancer Monoclonal Antibodies Clinical Pipeline by Company & Phase

32.1 Unknown

32.2 Research

32.3 Preclinical

32.4 Clinical

32.5 Phase-I

32.6 Phase-I/II

32.7 Phase-II

32.8 Phase-II/III

32.9 Phase-III

32.10 Registered

 

  1. Marketed Multiple Cancer Monoclonal Antibodies Clinical Insight

33.1 Cetuximab (Erbitux)

33.2 Nivolumab (Opdivo)

33.3 Bevacizumab (Avastin)

33.4 Trastuzumab (Herceptin)

33.5 Atezolizumab (TECENTRIQ)

33.6 Rituximab (MabThera & Rituxan)

33.7 Ramucirumab (Cyramza, Sairamza & Silamza)

33.8 Trastuzumab Biosimilar (Herzuma)

33.9 Pembrolizumab (Keytruda)

33.10 Pembrolizumab Companion Diagnostic (PD-L1 IHC 22C3 pharmDx)

33.11 Ipilimumab (Yervoy)

33.12 Trastuzumab Biosimilar (BIOMAb EGFR, CIMAher, Cimaher, Taixinsheng, TheraCIM, Theraloc & VECTHIX)

33.13 Nimotuzumab (BIOMAb EGFR, CIMAher, Cimaher, Taixinsheng, TheraCIM, Theraloc & VECTHIX)

33.14 Bevacizumab Biosimilar (KRABEVA)

33.15 Bevacizumab Biosimilar (Mvasi)

33.16 Trastuzumab Biosimilar (AryoTrust)

33.17 Satumomab (OncoScint CR/OV)

 

  1. Competitive Landscape

34.1 Abbvie

34.2 Amgen

34.3 Bayer HealthCare

34.4 Biogen Idec

34.5 Eli Lilly

34.6 Genmab

34.7 Gilead Sciences

34.8 GlaxoSmithKline

34.9 Novartis

34.10 Pfizer

34.11 Roche

34.12 Seattle Genetics

 

Sign up and submit a press release

Sponsored
New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

New Clarius Power Fan HD3 Delivers a First for Handheld Ultrasound: Continuous Scanning

Fluidx Unveils New Embolic for Neurovascular Use

Fluidx Unveils New Embolic for Neurovascular Use

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

Annalise.ai and Nuance Communications (a Microsoft Company) Announce Key Partnership to Improve Patient Outcomes with Workflow-Integrated AI

PT Genie Unveils New Brand Identity Reflecting Company’s Transformation and Focus on the Global Future of AI and Machine Learning in Digital Healthcare

Clarius Marketplace Unlocks the Power of AI Innovation for Ultrasound Imaging

Clarius Marketplace Unlocks the Power of AI Innovation for Ultrasound Imaging

interviews & reviews
Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Exciting Medtech at the Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Medgadget Visits Healthcareᐩ Expo Taiwan

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Diabetes Management Tech for Type II patients: Interview with Jeffrey Brewer, CEO of Bigfoot Biomedical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

Monitoring Congestive Heart Failure Through Speech: Interview with Tamir Tal, CEO of Cordio Medical

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

In-Office Pediatric Ear Tube Procedures: Interview with Preceptis Medical's Greg Mielke

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

Symani Microsurgical Robotic System: Interview with Mark Toland, CEO of Medical Microinstruments

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email